Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases

Magnetic Resonance in Medicine

Volumn 49, Issue 1, 2003, Pages 19-28

  Seeger, Uwe ^a   Klose, Uwe ^a   Mader, Irina ^a   Grodd, Wolfgang ^a   Nägele, Thomas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Brain spectroscopy; LCModel; Lipids; Macromolecules; Parameterization

Indexed keywords

BIOMOLECULES; BRAIN; DIAGNOSIS; LIPIDS; MACROMOLECULES; MAGNETIC RESONANCE SPECTROSCOPY; PARAMETERIZATION; TUMORS;

BRAIN METABOLITES; FITTING PROCEDURE; HIGH-GRADE GLIOMAS; LCMODEL; MULTIPLE SCLEROSIS; PRIOR KNOWLEDGE; PROTON MR SPECTROSCOPY; STANDARD BASIS;

METABOLITES;

LIPID;

ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; GLIOMA; HUMAN; IN VIVO STUDY; MACROMOLECULE; METABOLITE; MULTIPLE SCLEROSIS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; STANDARDIZATION;

EID: 0037225769     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10332     Document Type: Article

References (34)

1. Young K, Govindaraju V, Soher BJ, Maudsley AA. Automated spectral analysis. I. Formation of a priori information by spectral simulation. Magn Reson Med 1998;40:812-815.
2. De Graaf AA, Bovee WMMJ. Improved quantification of in vivo 1H NMR spectra by optimization of signal acquisition and processing and by incorporation of prior knowledge into the spectral fitting. Magn Reson Med 1990;15:305-319.
3. Mierisova S, van den Boogaart A, Tkac I, Van Hecke P, Vanhamme L, Liptaj T. New approach for quantitation of short echo time in vivo 1H MR spectra of brain using AMARES. NMR Biomed 1998;11:32-39.
4. Bartha R, Drost DJ, Williamson PC. Factors affecting the quantification of short echo in-vivo 1H MR spectra: Prior knowledge, peak elimination, and filtering. NMR Biomed 1999;12:205-216.
5. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
6. Behar KL, Rothman DL, Spencer DD, Petroff OAC. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994;32:294-302.
7. Hwang J-H, Graham GD, Behar KL, Alger JR, Prichard JW, Rothman DL. Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain. Magn Reson Med 1996;35:633-639.
8. Hofmann L, Slotboom J, Boesch C, Kreis R. Model fitting of 1H-MR spectra of the human brain: Incorporation of short-T1 components and evaluation of parameterized vs. non-parameterized models. In: Proceedings of the 7th Annual Meeting of ISMRM, Philadelphia, 1999. p 586.
9. Pfeuffer J, Tkac I, Provencher SW, Gruetter R. Toward an in vivo neurochemical profile: Quantification of 18 metabolites in short-echotime 1H NMR spectra of the rat brain. J Magn Reson 1999;141:104-120.
10. Frahm J, Bruhn H, Hänicke W, Merboldt K-D, Mursch K, Markakis E. Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. J Comput Assist Tomogr 1991;15:915-922.
11. Gotsis ED, Fountas K, Kapsalaki E, Toulas P, Peristeris G, Papadakis N. In vivo proton MR spectroscopy: The diagnostic possibilities of lipid resonances in brain tumors. Anticancer Res 1996;16:1565-1567.
12. Negendank W, Sauter R. Intratumoral lipids in 1H MRS in vivo in brain tumors: Experience of the Siemens cooperative clinical trial. Anticancer Res 1996;16:1533-1538.
13. Tien RD, Lai PH, Smith IS, Lazeyras F. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. Am J Roentgenol 1996;167:201-209.
14. Tate AR, Griffiths JR, Martinez-Perez I, Moreno A, Barba I, Cabanas ME, Watson D, Alonso J, Bartumeus F, Isamat F, Ferrer I, Vila F, Ferrer E, Capdevila A, Arus C. Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed 1998;11:177-191.
15. Barton SJ, Howe FA, Tomlins AM, Cudlip SA, Nicholson JK, Bell BA, Griffiths JR. Comparison of in vivo 1H MRS of human brain tumours with 1H HR-MAS spectroscopy of intact biopsy samples in vitro. MAGMA 1999;8:121-128.
16. Kaminogo M, Ishimaru H, Morikawa M, Ochi M, Ushijima R, Tani M, Matsuo Y, Kawakubo J, Shibata S. Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localized proton spectroscopy of brain. Neuroradiology 2001;43:353-363.
17. Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM. Discrimination of metabolite from lipid and macromolecule resonances in cerebral infarction in humans using short echo proton spectroscopy. J Magn Reson Imaging 1997;7:1116-1121.
18. Narayana PA, Wolinsky JS, Jackson EF, McCarthy M. Proton MR spectroscopy of gadolinium-enhanced multiple sclerosis plaques. J Magn Reson Imaging 1992;2:263-270.
19. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, McDonald WI. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58.
20. Kuesel AC, Donnelly SM, Halliday W, Sutherland GR, Smith ICP. Mobile lipids and metabolic heterogeneity of brain tumours as detectable by ex vivo 1H MR spectroscopy. NMR Biomed 1994;7:172-180.
21. Hwang J-H, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball Jr WS. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. Am J Neuroradiol 1998;19:535-540.
22. Kuesel AC, Sutherland GR, Halliday W, Smith ICP. 1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue. NMR Biomed 1994;7:149-155.
23. Kuesel AC, Briere KM, Halliday WC, Sutherland GR, Donnelly SM, Smith ICP. Mobile lipid accumulation in necrotic tissue of high grade astrocytomas. Anticancer Res 1996;16:1485-1489.
24. Howe FA, McLean MA, Saunders DE, Bell BA, Griffiths JR. Metabolite nulling in short echo time in vivo 1H MRS of human brain tumors. In: Proceedings of the 3rd Annual Meeting of ISMRM, Nice, France, 1995. p 1705.
25. Roser W, Hagberg G, Mader I, Dellas S, Seelig J, Radue EW, Steinbrich W. Assignment of glial brain tumors in humans by in vivo 1H-magnetic resonance spectroscopy and multidimensional metabolic classification. MAGMA 1997;5:179-183.
26. Auer DP, Gössl C, Schirmer T, Czisch M. Improved analysis of 1H-MR spectra in the presence of mobile lipids. Magn Reson Med 2001;46:615-618.
27. Slosman DO, Lazeyras F. Metabolic imaging in the diagnosis of brain tumors. Curr Opin Neurol 1996;9:429-435.
28. Mader I, Seeger U, Weissert R, Klose U, Naegele T, Melms A, Grodd W. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. Brain 2001;124:953-961.
29. Seeger U, Mader I, Nägele T, Grodd W, Lutz O, Klose U. Reliable detection of macromolecules in single-volume 1H NMR spectra of the human brain. Magn Reson Med 2001;45:948-954.
30. Klose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990;14:26-30.
31. Hofmann L, Slotboom J, Boesch C, Kreis R. Characterization of the macromolecule baseline in localized 1H-MR spectra of human brain. Magn Reson Med 2001;46:855-863.
32. Hagberg G, Burlina AP, Mader I, Roser W, Radue EW, Seelig J. In vivo proton MR spectroscopy of human gliomas: Definition of metabolic coordinates for multi-dimensional classification. Magn Reson Med 1995;34:242-252.
33. Manton DJ, Lowry M, Rowland-Hill C, Crooks D, Mathew B, Turnbull LW. Combined proton MR spectroscopy and dynamic contrast enhanced MR imaging of human intracranial tumours in vivo. NMR Biomed 2000;13:449-459.
34. Starcuk Z, Tkac I, Starcuk Jr Z, Horky J, Gruetter R. Measurement of macromolecule or metabolite nulled in vivo proton NMR spectra of the rat brain. In: Proceedings of the 7th Annual Meeting of ISMRM, Philadelphia, 1999. p 1582.